EMEA-000126-PIP01-07
Key facts
| Invented name |
Alimta
|
| Active substance |
pemetrexed disodium
|
| Therapeutic area |
Oncology
|
| Decision number |
P/34/2009
|
| PIP number |
EMEA-000126-PIP01-07
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Eli Lilly and Company Limited (US)
Tel.: +1 31 75448941 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|